A 48-year-old woman presents with a 3-month history of symmetrical polyarthritis affecting the small joints of both hands, morning stiffness lasting 2 hours, and progressive functional decline. Physical examination reveals swollen, tender metacarpophalangeal and proximal interphalangeal joints bilaterally. Which investigation is most specific for confirming the diagnosis of rheumatoid arthritis?

Explanation

## Diagnostic Specificity in Rheumatoid Arthritis **Key Point:** Anti-CCP antibodies are the most specific serological marker for rheumatoid arthritis, with specificity >95% and superior predictive value for erosive disease and poor prognosis compared to rheumatoid factor. ### Comparison of Serological Markers | Marker | Sensitivity | Specificity | Clinical Significance | Prognostic Value | |--------|-------------|-------------|----------------------|------------------| | Anti-CCP | 60–70% | >95% | Appears early; precedes symptoms | Predicts erosions & poor outcome | | RF (IgM) | 70–80% | 80–85% | Non-specific; present in other diseases | Moderate; less specific than anti-CCP | | ESR | 70–80% | <50% | Marker of inflammation only | Non-specific activity marker | | CRP | 60–70% | <50% | Acute phase reactant | Non-specific activity marker | **High-Yield:** Anti-CCP positivity identifies a subset of RA patients with aggressive disease, early joint damage, and systemic manifestations. It is positive even in seronegative (RF-negative) RA in ~30% of cases, making it superior for diagnosis. **Clinical Pearl:** Anti-CCP can be detected years before symptom onset, making it valuable for risk stratification in at-risk populations. A patient with early RA and positive anti-CCP should be treated aggressively with disease-modifying antirheumatic drugs (DMARDs) to prevent irreversible joint damage. **Warning:** ~~Rheumatoid factor~~ is less specific than anti-CCP and is found in other autoimmune conditions (SLE, Sjögren's syndrome), chronic infections, and even healthy elderly individuals. ESR and CRP are non-specific inflammatory markers and cannot confirm diagnosis alone. ### Diagnostic Algorithm ```mermaid flowchart TD A[Suspected RA: symmetrical polyarthritis + morning stiffness]:::outcome --> B{Order serology}:::decision B --> C[Anti-CCP antibodies]:::action B --> D[Rheumatoid Factor]:::action C -->|Positive| E[High specificity for RA<br/>Predicts erosions]:::outcome D -->|Positive| F[Moderate specificity<br/>Less predictive]:::outcome E --> G[Start DMARD therapy<br/>Prevent joint damage]:::action F --> H{Anti-CCP status?}:::decision H -->|Positive| G H -->|Negative| I[Seronegative RA<br/>Monitor closely]:::outcome ``` [cite:Robbins 10e Ch 6]